In a study published in Nature Nanotechnology, researchers discovered that cuproptosis may serve as a new target for ...

Researchers from Bulgaria conduct an analysis of the potential for therapeutic vaccines in by comparing testing results for ...

LEXINGTON, MA, USA I 13, 2024 I Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, presented data today at the European Society for ...

A study presented at the ESMO Congress shed light on an ADC directed against an immune checkpoint in PD-L1-expressing solid ...

Tempo Therapeutics, Inc. ("Tempo"), a leading innovator in tissue engineering and regenerative medicine, today announced the dosing of the first patients in a clinical trial of TT101 (the MOSAIC Trial ...

Entos ® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures and improve the lives of patients and their families, ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced it has completed a successful pre-Biologics ...

Announcing a new article publication for Zoonoses journal. Leishmaniases are transmitted by the protozoan parasite Leishmania through the bites of infected sandflies. Despite the availability of ...

The company received financial backing for trialling the surgical scaffolding product from J&J’s venture capital arm.

Today's authorization enables Novavax to launch our updated COVID-19 vaccine in the U.S. in pre-filled syringes, and we have ...